Wei Tu Selected Research

Wei Tu Research Topics

Disease

21	Neoplasms (Cancer) 09/2021 - 06/2005
9	Neoplasm Metastasis (Metastasis) 01/2021 - 08/2012
6	Inflammation (Inflammations) 01/2022 - 01/2019
6	Hepatocellular Carcinoma (Hepatoma) 05/2015 - 01/2013
5	Asthma (Bronchial Asthma) 01/2021 - 01/2019
5	Infections 02/2016 - 03/2009
4	Carcinogenesis 09/2021 - 05/2015
4	Respiratory Hypersensitivity 01/2021 - 01/2019
4	Hemolytic-Uremic Syndrome 02/2016 - 03/2009
3	Glioma (Gliomas) 09/2021 - 01/2017
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2021 - 07/2002
2	Autoimmune oophoritis 01/2022 - 06/2011
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2022
2	Reperfusion Injury 01/2021 - 01/2018
2	Lymphatic Metastasis 01/2021 - 06/2005
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 06/2014
2	COVID-19 01/2021 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2020 - 11/2019
2	Liver Neoplasms (Liver Cancer) 11/2019 - 01/2014
2	Brain Neoplasms (Brain Tumor) 12/2017 - 01/2017
2	Liver Cirrhosis (Hepatic Cirrhosis) 10/2016 - 01/2012
2	Communicable Diseases (Infectious Diseases) 12/2015 - 12/2013
2	Botulism 11/2010 - 09/2008
1	Multiple Myeloma 03/2022
1	Addison Disease (Addison's Disease) 01/2022
1	Primary Ovarian Insufficiency 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Lung Neoplasms (Lung Cancer) 09/2021
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2021
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021
1	Myocardial Infarction 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Flatulence 10/2020
1	Airway Remodeling 05/2020

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2009
5	AllergensIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
4	AntigensIBA 01/2022 - 06/2011
4	CytokinesIBA 01/2021 - 07/2002
4	VaccinesIBA 04/2019 - 05/2010
3	Environmental Pollutants (Pollutants, Environmental)IBA 09/2021 - 07/2016
3	CadmiumIBA 09/2021 - 05/2015
3	Circular RNAIBA 09/2021 - 01/2021
3	InflammasomesIBA 01/2021 - 11/2019
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 01/2020
3	SirtuinsIBA 01/2019 - 05/2015
2	AutoantigensIBA 01/2022 - 06/2011
2	EnzymesIBA 01/2022 - 01/2020
2	Sirtuin 1IBA 01/2021 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2021 - 07/2002
2	C-Reactive ProteinIBA 01/2021 - 03/2015
2	Dermatophagoides farinae antigen f 1IBA 01/2021 - 01/2019
2	Benzo(a)pyreneIBA 01/2021 - 01/2019
2	Biological ProductsIBA 05/2020 - 12/2017
2	LigandsIBA 01/2020 - 01/2014
2	Indicators and Reagents (Reagents)IBA 01/2020 - 07/2016
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2019 - 06/2005
2	Proteoglycans (Proteoglycan)IBA 04/2019 - 10/2015
2	MethyltransferasesIBA 12/2017 - 01/2017
2	ChromatinIBA 11/2016 - 08/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 05/2015 - 01/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2015 - 01/2013
2	Netrin-1IBA 01/2015 - 06/2014
2	Shiga Toxins (Vero Toxin)IBA 01/2011 - 12/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2003 - 07/2002
1	Proteasome InhibitorsIBA 03/2022
1	Immunologic Factors (Immunomodulators)IBA 03/2022
1	Monoclonal AntibodiesIBA 03/2022
1	idecabtagene vicleucelIBA 03/2022
1	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2022
1	SteroidsIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Janus Kinase InhibitorsIBA 01/2022
1	CateninsIBA 09/2021
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 09/2021
1	NADP (NADPH)IBA 01/2021
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2021
1	PeroxiredoxinsIBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 01/2021
1	NF-E2-Related Factor 2IBA 01/2021
1	MucinsIBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Troponin IIBA 01/2021
1	Sevoflurane (Ultane)FDA LinkGeneric 01/2021
1	Monomeric GTP-Binding ProteinsIBA 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	NucleosidesIBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Heme Oxygenase-1IBA 01/2021
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 05/2020
1	GTP Phosphohydrolases (GTPases)IBA 05/2020
1	rho-Associated KinasesIBA 05/2020

Therapy/Procedure

4	Therapeutics 01/2021 - 07/2002
2	Thymectomy 01/2022 - 06/2011
1	Stem Cell Transplantation 03/2022
1	Polypharmacy 01/2021